Trademark Overview
On Wednesday, January 29, 2025, a trademark application was filed for IVANO BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the IVANO BIOSCIENCE trademark a serial number of 99022612. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, October 22, 2025. This trademark is owned by AB VALIDATION INC.. The IVANO BIOSCIENCE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Custom design and development of chemical reagents and biochemical assays; research and development in the fields of assays, biological selection, medical screening, medical diagnostic testing, medical diagnostic imaging, and medical diagnostics using biomimicry technology; biochemical analysis; biochemical research; biomedical research services; biomedical research services, namely, preparation of biological samples for testing and analysis in research laboratories; research and development in the medical biotechnology field
Biological assays for research purposes in the fields of biological and diagnostic testing; kits comprised of biological assays and reagents for research purposes in the fields of biological and diagnostic testing; laboratory assay kits comprised of assays and reagents for research purposes; single-cell organisms for research use; Chemical diagnostic reagents for industrial use, namely, for use in biomanufacturing processes; genetically modified cells for research use; genome editing reagents for research use; viral vectors for research use; protein in raw material form for scientific and medical research; peptide substrates for scientific research purposes; diagnostic preparations in the nature of peptide substrates, other than for medical or veterinary purposes; nucleic acid sequences, other than for medical or veterinary purposes, namely, aptamers for research use; media for single-cell organism culture for research use
Medical diagnostic reagents and assays for testing of body fluids; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases; genetically modified cells for medical use, namely, diagnostic and therapeutic use; genome editing reagents for medical use, namely, diagnostic and therapeutic use; protein arrays for medical diagnosis purposes; diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; synthetic peptides for the treatment of cancer, genetic disorders, viral and infectious diseases; nucleic acid sequences for medical and veterinary purposes, namely, aptamers for diagnostic and therapeutic use; media for single-cell organism culture for medical use; single-cell organisms for medical use, namely, diagnostic and therapeutic use
